Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Diagnostic Tests Evaluated for Human Leptospirosis

By LabMedica International staff writers
Posted on 08 Aug 2013
The diagnosis of leptospirosis is often performed by the microscopic agglutination test (MAT) or by culture, but is confined to specialized laboratories.

Rapid Diagnostic Tests (RDTs) can be used for easy point-of-care diagnosis and three commercial kits have been evaluated for their diagnostic performance and compared with other standard assays. More...


Scientists at the Royal Tropical Institute (KIT; Amsterdam, The Netherlands) tested samples sent to their laboratory for leptospirosis diagnosis from July 2001 to August 2012. Blood, plasma, serum, and urine samples were cultured. The MAT was performed with a panel of live leptospires, and consisted of 16 strains of pathogenic serovars. An in-house enzyme-linked immunosorbent assay (ELISA) was developed for the detection of Leptospira-specific immunoglobulin M antibodies (IgM ELISA) and was performed with antigen prepared from the local strain Wijnberg (serovar Copenhageni, serogroup Icterohaemorrhagiae).

Three rapid diagnostic serological tests were used: Lepto Tek Dri Dot and Lepto Tek Lateral Flow (Organon Teknika B.V.; Boxtel, the Netherlands); and Leptocheck-WB, (Zephyr Biomedicals; Verna, Goa, India). Lepto Tek Lateral Flow and Leptocheck-WB are lateral flow immunochromatographic tests and LeptoTek Dri Dot is a latex agglutination assay and detects Leptospira-specific antibodies (IgM and IgG) in human sera.

The overall sensitivity for the LeptoTek Dri Dot was 75%, for the Lepto Tek Lateral, it was 78% Flow and 78% for the Leptocheck-WB. Specificity ranged from 95% to 98% in the three RDTs. Based on the first submitted sample the sensitivity was low, 51% for LeptoTek Dri Dot, 69% for Lepto Tek Lateral Flow, and 55% for Leptocheck-WB, but substantially increased when the results of paired samples were combined, although accompanied by a lower specificity, 82% for Lepto Tek Dri Dot, 86% for Lepto Tek Lateral Flow, and 80% for Leptocheck-WB.


The authors concluded that The LeptoTeK Lateral Flow presents in all scenarios with the best sensitivity and equally good specificity of all three RDT tests. All three tests, LeptoTek Dri Dot, LeptoTek Lateral Flow, and Leptocheck-WB present useful antibody tests contributing to the diagnosis of leptospirosis. However, since the overall sensitivity of the tested RDTs did not exceed 80%, one should be cautious to rely only on an RDT result, and confirmation by reference tests is strongly recommended. The study was published on July 11, 2013, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Dutch Royal Tropical Institute

Organon Teknika B.V

Zephyr Biomedicals



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.